Abstract Library

#2124 A Case Report of a Malignant Insulinoma

Introduction: Despite rare (1-2% of pancreatic tumors/PT), insulinomas are the most common functional pNET. The diagnosis is established by demonstrating inappropriately high serum insulin levels during a spontaneous or induced episode of hypoglycemia.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Zoumblios C, Tegos T, Kyriakopoulos G, Argyrakos T, Alevizopoulos N,

Keywords: malignant, insulinoma,

#1930 Concomitant Intraductal Papillary Mucinous Neoplasms and Neuroendocrine Tumors of the Pancreas: More than just a Coincidence?

Introduction: Intraductal papillary mucinous neoplasms (IPMNs) and pancreatic neuroendocrine tumors (pNETs) are rare tumors. Up to now 14 patients with association of endocrine and exocrine neoplasms of the pancreas have been reported in literature: this association is not expected to be frequent

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Cortegoso Valdivia P

Authors: Venezia L, Cortegoso Valdivia P, De Angelis C,

Keywords: IPMN, NET, pancreas,

#1928 Pancreatic Involvement in VHL Disease: The Turin Experience

Introduction: Von Hippel-Lindau disease (VHL) is a rare heritable genetic syndrome. Its typical manifestations concern CNS but it may affect other organs such as the pancreas.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Cortegoso Valdivia P

Authors: Cortegoso Valdivia P, Venezia L, De Angelis C,

Keywords: VHL,

#1846 Metachronous Pancreatic Neuroendocrine Tumors. An Unusual Interesting Case Report

Introduction: Literature surveillance state that in multiple endocrine neoplasia (MEN) disease, frequently occur, synchronous or metachronous neuroendocrine tumors (NETs) but in non-MEN patients are extremely rare.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Vaslamatzis M, Alevizopoulos N, Tegos T, Argyrakos T,

Keywords: pancreatic,

#1085 Antiproliferative Effect of Lanreotide in Low Grade Neuroendocrine Neoplasms: Two Case Reports

Introduction: Somatostatin analogs are used for control of symptoms due to hormonal hypersecretion by neuroendocrine neoplasms (NEN). Their antiproliferative effect only recently became evident. Data on pancreatic NEN (pNEN) are limited.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Vaslamatzis M, Tegos T, Alevizopoulos N, Stathopoulos C, Argyrakos T,

Keywords: NEN, lanreotide,